Evaluation of the Efficacy of Biobran (Rice Bran Arabinoxylan) in Supporting Breast Cancer Chemotherapy

Recruiting now · Not applicable

Conditions studied: Breast Cancer Stages I, Breast Cancer Stages II, Breast Cancer Stage III

In brief

This study aims to evaluate the potential supportive effects of rice bran arabinoxylan compound (Biobran) in patients with breast cancer receiving paclitaxel and doxorubicin chemotherapy. The study will assess chemotherapy-related side effects, quality of life, tumor size, tumor antigens, and routine blood test parameters over 24 weeks of treatment.

Key facts

Study ID

NCT07503496

Run by

China Medical University Hospital

People needed

96

Starts

2025-04-07

Expected to finish

2026-08-31

Last updated by the study team

2026-03-31

Who can join

Age: 20 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Breast cancer stage I-III

You may not qualify if…

• pregnant, lactation, breast recurrence, mental disease, autoimmune disease over hte past 5 years, people who take plant or fungal polysaccharide health supplements

Where it is running

• China Medical University Hospital — Taichung, Taiwan (enrolling)
• China Medical University — Taichung, Taiwan

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.